Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
J Immunol ; 142(12): 4241-7, 1989 Jun 15.
Article in English | MEDLINE | ID: mdl-2498428

ABSTRACT

We examined the effect of type I IFN inducers and rIFN-alpha on MHC expression in mouse tissues in vivo. MHC expression was assessed in a radiolabeled mAb binding assay and by indirect immunoperoxidase staining of tissue sections. polyI:C, an inducer of IFN-alpha/beta, induced large increases in class I MHC in many tissues, with little effect on class II expression. In the kidney, which was studied in detail, polyI:C increased class I expression from day 1 to day 6, localized in glomeruli, tubules, and arterial endothelium. Renal class II MHC was less affected but tended to be decreased at days 3 to 6, corresponding to diminished staining of class II-positive interstitial cells. polyI:C increased renal class I MHC in nude mice and mice with severe combined immunodeficiency, and in mice treated with cyclosporine or mAb against IFN-gamma. The effects of influenza virus resembled those of polyI:C. However, a potent T cell stimulus, allogeneic ascites tumor cells, induced markedly different MHC changes, with massive and sustained increases in class I and II, presumably due to IFN-gamma release, which was inhibited by cyclosporine or by mAb against IFN-gamma. The effect of polyI:C was largely simulated by rIFN-alpha, whereas the effect of allogeneic cells was simulated by rIFN-gamma. Thus, rIFN-alpha and its inducers in vivo produce a sustained increase in renal class I expression in kidney and other tissues, sometimes with changes in class II expression. Such effects could be relevant to the immune modulatory actions of IFN, and to the immunologic consequences of viral infections.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Histocompatibility Antigens Class II/analysis , Histocompatibility Antigens Class I/analysis , Interferon Inducers/administration & dosage , Interferon Type I/administration & dosage , Animals , Antibodies, Monoclonal/administration & dosage , Cyclosporins/administration & dosage , Female , Influenza A virus/immunology , Interferon-gamma/administration & dosage , Interferon-gamma/immunology , Kidney/analysis , Kidney/drug effects , Mice , Mice, Inbred A , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred DBA , Mice, Nude , Organ Specificity/drug effects , Poly I-C/administration & dosage , Recombinant Proteins , Species Specificity/drug effects
2.
Arch Biochem Biophys ; 269(1): 25-31, 1989 Feb 15.
Article in English | MEDLINE | ID: mdl-2644894

ABSTRACT

Peroxidative oxidation of dichlorobenzidine in vitro results in covalent binding to exogenous DNA. In a modified Ames assay, mutagenicity is observed in S. typhimurium strain TA98 following the incubation of dichlorobenzidine, bacteria, and hydrogen peroxide. In this paper, we demonstrate that [14C]dichlorobenzidine becomes covalently bound to S. typhimurium macromolecules, including DNA, when exogenous hydrogen peroxide is supplied. We compared the levels of binding in a pair of otherwise isogenic strains with wild-type (oxyR+) versus constitutive (oxyR1) expression of the hydrogen peroxide stress-induced regulon. Binding was approximately twofold higher in TA4124 (oxyR1) than in TA4123 (oxyR+). Bacterial hydroperoxidases may catalyze the activation of dichlorobenzidine to mutagenic and DNA binding species in this system.


Subject(s)
3,3'-Dichlorobenzidine/toxicity , Benzidines/toxicity , DNA/drug effects , Hydrogen Peroxide/toxicity , Salmonella typhimurium/drug effects , Catalase/isolation & purification , Catalase/metabolism , Catalysis , DNA/metabolism , Hydrogen Peroxide/metabolism , Macromolecular Substances , Mutagenicity Tests , Salmonella typhimurium/enzymology , Salmonella typhimurium/genetics , Species Specificity/drug effects
3.
J Immunol ; 135(6): 4289-96, 1985 Dec.
Article in English | MEDLINE | ID: mdl-3934281

ABSTRACT

Highly purified human blood monocytes, isolated by continuous Percoll density gradients under endotoxin-free conditions, and mouse peritoneal exudate macrophages (PEM) were activated in vitro by the combination of muramyl dipeptide (MDP) and recombinant interferon-gamma (r-IFN-gamma) to become tumoricidal against their respective tumorigenic target cells. The activation of human monocytes or mouse PEM by free unencapsulated r-IFN-gamma and MDP was species specific: human r-IFN-gamma activated human blood monocytes to lyse allogeneic melanoma cells, but did not activate mouse PEM. Mouse r-IFN-gamma activated mouse PEM to lyse syngeneic melanoma cells, but did not activate cytotoxic properties in human monocytes. The encapsulation of either mouse or human r-IFN-gamma with MDP within the same liposome preparation produced synergistic activation of cytotoxic properties in both PEM and monocytes without apparent species specificity. The activation of tumoricidal properties in macrophages by r-IFN-gamma and MDP occurred as a consequence of intracellular interaction. We base this conclusion on the data showing that whereas free r-IFN-gamma and MDP did not activate macrophages pretreated with pronase, liposome-encapsulated r-IFN-gamma and MDP did. Moreover, the i.v. injection of liposomes containing human or mouse r-IFN-gamma and MDP produced in vivo activation of mouse alveolar macrophages. These data suggest that in contrast to activation with free r-IFN-gamma, which requires binding to macrophage surface receptors, the intracellular interaction of r-IFN-gamma, which produces tumoricidal activity in macrophages, is not species specific.


Subject(s)
Interferon-gamma/pharmacology , Liposomes/pharmacology , Macrophage Activation/drug effects , Macrophages/immunology , Recombinant Proteins/pharmacology , Species Specificity/drug effects , Acetylmuramyl-Alanyl-Isoglutamine/administration & dosage , Acetylmuramyl-Alanyl-Isoglutamine/pharmacology , Animals , Humans , Interferon-gamma/administration & dosage , Liposomes/administration & dosage , Macrophages/drug effects , Mice , Mice, Inbred C57BL , Phagocytosis/drug effects , Pronase/pharmacology , Pulmonary Alveoli/cytology , Recombinant Proteins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...